Literature DB >> 28275012

Dangerous fusions: a path to cancer for arrested lymphoid progenitors.

Ameera Alsadeq1, Hassan Jumaa1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28275012      PMCID： PMC5350558          DOI： 10.15252/embj.201796686

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  11 in total

1.  PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).

Authors:  S Strehl; M König; M N Dworzak; K Kalwak; O A Haas
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

2.  Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.

Authors:  Etienne Coyaud; Stephanie Struski; Nais Prade; Julien Familiades; Ruth Eichner; Cathy Quelen; Marina Bousquet; Francine Mugneret; Pascaline Talmant; Marie-Pierre Pages; Christine Lefebvre; Dominique Penther; Eric Lippert; Nathalie Nadal; Sylvie Taviaux; Bruce Poppe; Isabelle Luquet; Laurence Baranger; Virginie Eclache; Isabelle Radford; Carole Barin; Marie-Joëlle Mozziconacci; Marina Lafage-Pochitaloff; Hélène Antoine-Poirel; Christiane Charrin; Christine Perot; Christine Terre; Pierre Brousset; Nicole Dastugue; Cyril Broccardo
Journal:  Blood       Date:  2010-02-16       Impact factor: 22.113

3.  Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.

Authors:  Leonie Smeenk; Maria Fischer; Sabine Jurado; Markus Jaritz; Anna Azaryan; Barbara Werner; Mareike Roth; Johannes Zuber; Martin Stanulla; Monique L den Boer; Charles G Mullighan; Sabine Strehl; Meinrad Busslinger
Journal:  EMBO J       Date:  2017-02-20       Impact factor: 11.598

4.  The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case.

Authors:  G Cazzaniga; M Daniotti; S Tosi; G Giudici; A Aloisi; E Pogliani; L Kearney; A Biondi
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

5.  How I treat relapsed childhood acute lymphoblastic leukemia.

Authors:  Franco Locatelli; Martin Schrappe; Maria Ester Bernardo; Sergio Rutella
Journal:  Blood       Date:  2012-08-15       Impact factor: 22.113

6.  Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.

Authors:  Louise van der Weyden; George Giotopoulos; Alistair G Rust; Louise S Matheson; Frederik W van Delft; Jun Kong; Anne E Corcoran; Mel F Greaves; Charles G Mullighan; Brian J Huntly; David J Adams
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

7.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.

Authors:  César Cobaleda; Wolfram Jochum; Meinrad Busslinger
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

8.  Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.

Authors:  K Nebral; D Denk; A Attarbaschi; M König; G Mann; O A Haas; S Strehl
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

9.  Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.

Authors:  Lynn M Heltemes-Harris; Mark J L Willette; Laura B Ramsey; Yi Hua Qiu; E Shannon Neeley; Nianxiang Zhang; Deborah A Thomas; Thearith Koeuth; Emily C Baechler; Steven M Kornblau; Michael A Farrar
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

10.  Dominant-negative mechanism of leukemogenic PAX5 fusions.

Authors:  N Kawamata; M A Pennella; J L Woo; A J Berk; H P Koeffler
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.